Vincent M Carace, RPH - Pharmacist in Concord, NH

Vincent M Carace, RPH is a Pharmacist - Geriatric based in Concord, New Hampshire. Vincent M Carace is licensed to practice in New Hampshire (license number 2416) and his current practice location is 1 Granite Pl, Concord, New Hampshire. He can be reached at his office (for appointments etc.) via phone at (603) 226-8686.

NPI number for Vincent M Carace is 1568921492 and his current mailing address is 49 James Dr, Hampstead, New Hampshire. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1568921492.

Contact Information

Vincent M Carace, RPH
1 Granite Pl,
Concord, NH 03301-3271
(603) 226-8686
Not Available

Healthcare Provider's Profile

Full NameVincent M Carace
GenderMale
SpecialityPharmacist - Geriatric
Location1 Granite Pl, Concord, New Hampshire
Accepts Medicare AssignmentsDoes not participate in Medicare Program. He may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1568921492
  • Provider Enumeration Date: 03/19/2019
  • Last Update Date: 06/11/2019

Medical Identifiers

Medical identifiers for Vincent M Carace such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1568921492NPI-NPPES
2416OtherNHPHARMACIST

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
1835G0303XPharmacist - Geriatric 2416 (New Hampshire)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Vincent M Carace is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Vincent M Carace, RPH
49 James Dr,
Hampstead, NH 03841-2196

Ph: (603) 223-3141
Vincent M Carace, RPH
1 Granite Pl,
Concord, NH 03301-3271

Ph: (603) 226-8686

News Archive

Vertex VX-509 12-week Phase 2a study on RA meets two primary endpoints

Vertex Pharmaceuticals Incorporated today announced that treatment with the investigational selective oral JAK3 inhibitor VX-509 in a Phase 2a trial resulted in substantial and statistically significant improvements in multiple measurements of rheumatoid arthritis (RA) activity.

Current progress on highly sensitive and flexible nano-structured materials

Advancement in technology is making life easier. However, innovation in nano-materials has made them important enough and now they are represented as the most promising class of new materials due to their intriguing optical, electronic and redox properties.

Two St. Louis institutions collaborate to create Center for Clinical Pharmacology

St. Louis College of Pharmacy and Washington University School of Medicine in St. Louis are joining forces to find better, safer and more effective ways to use prescription medications to improve health. Researchers from the two institutions are collaborating to create the Center for Clinical Pharmacology.

United Therapeutics announces withdrawal of Tyvaso European MAA for treatment of PAH

United Therapeutics Corporation announced today that it has withdrawn its Marketing Authorization Application (MAA) for Tyvaso (treprostinil sodium) 0.6 mg/ml nebuliser solution for the treatment of pulmonary arterial hypertension (PAH) in the European Union.

Penn researchers awarded $10 million grant to study adverse health effects, remediation of asbestos

Researchers at the Center of Excellence in Environmental Toxicology, Perelman School of Medicine at the University of Pennsylvania, have been awarded a $10 million grant from the National Institute for Environmental Health Sciences over the next four years to study asbestos exposure pathways that lead to mesothelioma, the bioremediation of this hazardous material, and mechanisms that lead to asbestos-related diseases.

Read more News

› Verified 3 days ago


Pharmacist in Concord, NH

Mr. Richard Jon Tripp, RPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 250 Pleasant St, Concord, NH 03301
Phone: 603-225-2711    
Mr. John Michael Tracy Sr., RPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 38 Locke Rd, Suite 3, Concord, NH 03301
Phone: 603-223-0380    Fax: 603-223-0347
Mary Kate Langlais-mcnutt, RPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 92 South St, Concord, NH 03301
Phone: 603-228-8400    
Mr. John Christopher Wakelin, RPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 125 N Main St, Concord, NH 03301
Phone: 603-224-9591    Fax: 603-224-5361
Joseph Pirani,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 1 Granite Pl Ste N200, Concord, NH 03301
Phone: 603-226-8686    
Mrs. Ann Marie Bisson, RPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 125 N Main St, Concord, NH 03301
Phone: 603-224-9591    
Mr. Khiem D Nguyen,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 4 Hall St, Concord, NH 03103
Phone: 603-623-3532    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.